THE GENETIC AND BIOCHEMICAL CONTRIBUTION OF AN ACTIVE ANDROGEN INFLUX TRANSPORTER, OATP1B3, IN PROSTATE CANCER FOR INHIBITOR DEVELOPMENT

$75,870FY2010Department of DefenseDOD

The Geneva Foundation

Investigators